Elizabeth Robinson, co-founder of NicOx, has served as the President of the NicOx Research Institute Srl since January 2006. Dr. Robinson has extensive experience in the development of innovative pharmaceutical components. She is a founding member and shareholder of Relivia Srl, an Italian company specialized in dermatology. She was Chairman of the Board of Directors of LayLine Genomics (2007-2008), Director of Development at Recordati Italie (1990-1996), a consultant in technological development for Techint Engineering Company (1988-1990), Vice President, New Technology Ventures, at Genzyme (1985-1988), a visiting scientist at Massachusetts Institute of Technology (MIT) (1984-1987), an assistant at MIT (1983) and a postdoctorate research assistant at MIT (1982-1984). 

Dr. Robinson graduated Phi Beta Kappa from Wellesley College in 1977. She received a Masters in Chemistry and a Doctorate in biotechnology from MIT in 1979 and 1982, respectively. 

She is also a member of “Italian Angels for Growth” and “First Generation” in Italy. She is a member of the Fulbright Commission in Italy and of the Board of Directors of Biogenera.